Navigation Links
Par Pharmaceutical Companies Reports Second Quarter 2011 Results
Date:8/3/2011

ts, net65,57395,467Goodwill63,72963,729Other assets6,6245,441Non-current deferred income tax assets, net56,39569,488Total assets$914,759$783,232LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable$27,381$23,956Payables due to distribution agreement partners50,43525,310Accrued salaries and employee benefits 10,40116,397Accrued government pricing liabilities32,14832,169Accrued legal fees8,6047,084Accrued legal settlements195,400-Accrued expenses and other current liabilities8,2776,674Total current liabilities332,646111,590Long-term liabilities42,81043,198Commitments and contingencies--Stockholders' equity:Common Stock, par value $0.01 per share, authorized 90,000,000 shares; issued39,655,227 and 38,872,663 shares394389Additional paid-in capital391,664373,764Retained earnings229,212329,129Accumulated other comprehensive gain68137Treasury stock, at cost 3,170,185 and 2,970,573 shares(82,035)(74,975)Total stockholders' equity539,303628,444Total liabilities and stockholders' equity$914,759$783,232Reconciliation Between Reported (GAAP); Adjusted Income (Loss) from Continuing Operations and "Cash EPS"(In Thousands, Except Per Share Data)

(Unaudited)Three Months EndedJune 30,June 30,20112010Income from Continuing Operations$9,180$18,035Restructuring costs

27,660-Upfront and development milestone payments

-17,000Litigation settlements and contingencies

-(4,130)Non-cash interest expense

-524Sum of adjustments, pre-tax

$27,660$13,394Estimated tax on adjustments

(10,234)(5,090)Charge related to valuation of deferred income tax assets

2,391-Resolution of tax contingencies

-(3,657)Adjusted Income from Continuing Operations (non-GAAP measure)

$28,997$22,682Amortization Expense

3,0133,904Estimated tax impact

(1,115)(1,484)Amortization Expense, net of tax

1,8982,420Adjusted Cash basis from Continuing Operations (non-GAAP measure)30,89525,102"Cash EPS" from Continuing Operati
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects?
2. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of August 2011
3. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
4. Pacira Pharmaceuticals, Inc. Announces Data Presentations at the 38th Annual Meeting & Exposition of the Controlled Release Society
5. MAP Pharmaceuticals Announces FDA Acceptance for Filing of NDA for LEVADEX®
6. Novo Nordisk and Partnership of Ivy Equities, LCOR and Intercontinental RE Corp. Announce Lease Agreement for N.J. Pharmaceutical Companys New U.S. Headquarters
7. FDA Grants Orphan Drug Status to Merrimack Pharmaceuticals MM-398, a Nanotherapeutic Encapsulation of Irinotecan, for the Treatment of Pancreatic Cancer
8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
9. BGI and GT Life Sciences, Inc. Report Genome Sequence of CHO-K1 and Provide New Insights into Optimization of Biopharmaceutical Protein Production
10. Though Essential to Pharmaceutical Sales Success, the Use of Health Outcomes Data Often Overlooked by Sales Leaders
11. Anthera Pharmaceuticals Reports 2011 Second Quarter Financial Results and Operational Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... VIEW, California , 20 de octubre de ... líder en el campo de la pulmonología intervencional, ... su Estudio RENEW, casi 3 meses antes de ... fundamental de exención de dispositivo de investigación (IDE) ... Medicamentos) para el sistema de espiral de reducción ...
(Date:10/20/2014)... Oct. 20, 2014 Valeritas, Inc., a leader ... patients with Type 2 diabetes, announced today that it ... Award. The award was presented October 16 th ... Columbus, Ohio . The Cardinal ... a variety of metrics specifically targeted at the importance ...
(Date:10/20/2014)... Oct. 20, 2014 Lpath, Inc. (NASDAQ: ... bioactive lipid-targeted therapeutics, received official notification from the European ... another key patent supporting its iSONEP™ and ASONEP™ ... European patent No. 2087002, claims compositions of matter ... two lead compounds, iSONEP and ASONEP. Sonepcizumab is ...
Breaking Medicine Technology:PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 2Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 2Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 4
... Company (Nasdaq: PRGO;TASE) today announced that Perrigo CFO Judy Brown ... 5, 2011 at 9:30 a.m. (IST) at the TASE Headquarters ... The day will include presentations on the Consumer Healthcare, ... and research and development. Perrigo Company is ...
... PARK, Calif., Oct. 4, 2011 CV Ingenuity, a ... a $16 million Series B round of financing led ... capital firm. Existing investors BioStar Ventures, Synergy Ventures and ... (CVI), which is focused on the development of a ...
Cached Medicine Technology:CV Ingenuity Announces Close of $16 Million Series B Financing Led by NEA 2
(Date:10/20/2014)... Silver Spring, Maryland, USA (PRWEB) October 20, 2014 ... readers or to track interventions? Here comes a wonderful ... leading mobile app development company helped its ... track Intervention more efficiently. The app is designed for ... iPad, and iPod touch. This app is optimized for ...
(Date:10/19/2014)... Recently, BambooIndustry.com, one of the most popular suppliers of ... bamboo deckings . Moreover, the company has launched a ... available at deeply discounted rates. , As is ... the significance of online business nowadays. Thus, BambooIndustry.com pays ... workers are striving to deliver both value and efficiency ...
(Date:10/19/2014)... Having been working in the garment industry for decades, ... According to James, one of the company’s top designers, many ... high-low skirts that add beauty to them. Chiffon floor length ... unveiled its new selection of 2014 long prom dresses. ... items are available in over 20 popular designs. The company ...
(Date:10/19/2014)... 2014 SweetDressy.com, a professional company of ... promotion for long evening dresses . All the ... offer; the current discount is up to 66 percent ... pioneers in the fashion field. Its dress specialists are ... in various parts of the world. All the company’s ...
(Date:10/19/2014)... Oct. 19, 2014 (HealthDay News) -- New stem cell-based ... lead to new treatments, a new study suggests. ... human intestinal tissue in a lab dish. They then ... for studying intestinal disorders, according to the researchers. ... diseases and conditions that can cause intestinal failure, from ...
Breaking Medicine News(10 mins):Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2Health News:Promotion For Beautiful Long Evening Dresses Launched By SweetDressy.com 2Health News:Scientists Grow, Implant Human Intestinal Tissue in Mice 2
... that the actress' current rehab spell will bring a stop ... incidents . ,As the Mean Girls star checked ... 28, after being arrested for DUI, her supposed friends got ... ,One friend told America's Star magazine that Lohan attempted to ...
... Laboratories Inc. today announced that Mylan Pharmaceuticals Inc. ... and Drug Administration (FDA) for its Abbreviated ... Tablets, 12.5 mg and 25 mg. ,Mylan's ... June 29, 2007, concurrent with the expiration of ...
... the explosive growth of smoke-free air laws worldwide ... now protected by laws that require smoke-free air in ... momentum behind smoke-free air laws will continue accelerating because ... to protect the public from secondhand smoke. ...
... announced today the presentation of new analysis of data ... on the clinical development of their investigational drug, Viprinex(TM) ... the 16th annual European Stroke Congress in Glasgow, Scotland ... derived from the venom of the Malayan pit viper. ...
... our nation, Americans are very optimistic about the war ... nationwide survey sponsored by Abbott, nearly two-thirds (64%) believe ... ,"As an organization researching new options to ... will live up to the optimism expressed by Americans ...
... global public health community observes World No Tobacco Day, the ... epidemic that tobacco causes for our nation. Two important new ... can address the deadly toll of tobacco -- especially secondhand ... Tobacco Day. ,The Institute of Medicine, the group ...
Cached Medicine News:Health News:Growth of Smoke-Free Air Laws Worldwide; More Than 200 Million Found "Fully Protected" 2Health News:Investigational Drug Being Pursued for the Treatment of Ischaemic Stroke 2Health News:Americans Optimistic About the War on Cancer 2Health News:World No Tobacco Day Focuses on Secondhand Smoke 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: